These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 27076138)

  • 1. Single-Vector, Single-Injection Recombinant Vesicular Stomatitis Virus Vaccines Against High-Containment Viruses.
    Whitt MA; Geisbert TW; Mire CE
    Methods Mol Biol; 2016; 1403():295-311. PubMed ID: 27076138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant vesicular stomatitis virus vaccine vectors expressing filovirus glycoproteins lack neurovirulence in nonhuman primates.
    Mire CE; Miller AD; Carville A; Westmoreland SV; Geisbert JB; Mansfield KG; Feldmann H; Hensley LE; Geisbert TW
    PLoS Negl Trop Dis; 2012; 6(3):e1567. PubMed ID: 22448291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chikungunya, Influenza, Nipah, and Semliki Forest Chimeric Viruses with Vesicular Stomatitis Virus: Actions in the Brain.
    van den Pol AN; Mao G; Chattopadhyay A; Rose JK; Davis JN
    J Virol; 2017 Mar; 91(6):. PubMed ID: 28077641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heat shock protein 70 enhances mucosal immunity against human norovirus when coexpressed from a vesicular stomatitis virus vector.
    Ma Y; Duan Y; Wei Y; Liang X; Niewiesk S; Oglesbee M; Li J
    J Virol; 2014 May; 88(9):5122-37. PubMed ID: 24574391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of VSV pseudotypes using recombinant ΔG-VSV for studies on virus entry, identification of entry inhibitors, and immune responses to vaccines.
    Whitt MA
    J Virol Methods; 2010 Nov; 169(2):365-74. PubMed ID: 20709108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant vesicular stomatitis virus-based vaccines against Ebola and Marburg virus infections.
    Geisbert TW; Feldmann H
    J Infect Dis; 2011 Nov; 204 Suppl 3(Suppl 3):S1075-81. PubMed ID: 21987744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment of replication-competent vesicular stomatitis virus recapitulating SADS-CoV entry.
    Zhu Z; Han Y; Gong M; Sun B; Zhang R; Ding Q
    J Virol; 2024 May; 98(5):e0195723. PubMed ID: 38557247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccination With a Highly Attenuated Recombinant Vesicular Stomatitis Virus Vector Protects Against Challenge With a Lethal Dose of Ebola Virus.
    Matassov D; Marzi A; Latham T; Xu R; Ota-Setlik A; Feldmann F; Geisbert JB; Mire CE; Hamm S; Nowak B; Egan MA; Geisbert TW; Eldridge JH; Feldmann H; Clarke DK
    J Infect Dis; 2015 Oct; 212 Suppl 2(Suppl 2):S443-51. PubMed ID: 26109675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Single-Vector, Single-Injection Trivalent Filovirus Vaccine: Proof of Concept Study in Outbred Guinea Pigs.
    Mire CE; Geisbert JB; Versteeg KM; Mamaeva N; Agans KN; Geisbert TW; Connor JH
    J Infect Dis; 2015 Oct; 212 Suppl 2(Suppl 2):S384-8. PubMed ID: 25957964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetically modified VSV(NJ) vector is capable of accommodating a large foreign gene insert and allows high level gene expression.
    An HY; Kim GN; Wu K; Kang CY
    Virus Res; 2013 Jan; 171(1):168-77. PubMed ID: 23207069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A viable recombinant rhabdovirus lacking its glycoprotein gene and expressing influenza virus hemagglutinin and neuraminidase is a potent influenza vaccine.
    Ryder AB; Buonocore L; Vogel L; Nachbagauer R; Krammer F; Rose JK
    J Virol; 2015 Mar; 89(5):2820-30. PubMed ID: 25540378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of a novel recombinant vesicular stomatitis virus with triple mutations in its matrix protein as a vaccine for pigs.
    Fang X; Qi B; Ma Y; Zhou X; Zhang S; Sun T
    Vaccine; 2015 Nov; 33(46):6268-76. PubMed ID: 26431989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two Point Mutations in Old World Hantavirus Glycoproteins Afford the Generation of Highly Infectious Recombinant Vesicular Stomatitis Virus Vectors.
    Slough MM; Chandran K; Jangra RK
    mBio; 2019 Jan; 10(1):. PubMed ID: 30622188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant vesicular stomatitis virus vector vaccines for WHO blueprint priority pathogens.
    Fathi A; Dahlke C; Addo MM
    Hum Vaccin Immunother; 2019; 15(10):2269-2285. PubMed ID: 31368826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Live virus vaccines based on a vesicular stomatitis virus (VSV) backbone: Standardized template with key considerations for a risk/benefit assessment.
    Clarke DK; Hendry RM; Singh V; Rose JK; Seligman SJ; Klug B; Kochhar S; Mac LM; Carbery B; Chen RT;
    Vaccine; 2016 Dec; 34(51):6597-6609. PubMed ID: 27395563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vesicular stomatitis virus-based vaccines against Lassa and Ebola viruses.
    Marzi A; Feldmann F; Geisbert TW; Feldmann H; Safronetz D
    Emerg Infect Dis; 2015 Feb; 21(2):305-7. PubMed ID: 25625358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospects for immunisation against Marburg and Ebola viruses.
    Geisbert TW; Bausch DG; Feldmann H
    Rev Med Virol; 2010 Nov; 20(6):344-57. PubMed ID: 20658513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vesicular stomatitis virus as a vector to deliver virus-like particles of human norovirus: a new vaccine candidate against an important noncultivable virus.
    Ma Y; Li J
    J Virol; 2011 Mar; 85(6):2942-52. PubMed ID: 21228240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Properties of replication-competent vesicular stomatitis virus vectors expressing glycoproteins of filoviruses and arenaviruses.
    Garbutt M; Liebscher R; Wahl-Jensen V; Jones S; Möller P; Wagner R; Volchkov V; Klenk HD; Feldmann H; Ströher U
    J Virol; 2004 May; 78(10):5458-65. PubMed ID: 15113924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lassa-vesicular stomatitis chimeric virus safely destroys brain tumors.
    Wollmann G; Drokhlyansky E; Davis JN; Cepko C; van den Pol AN
    J Virol; 2015 Jul; 89(13):6711-24. PubMed ID: 25878115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.